对成年患有过敏性鼻炎的患者使用抗组胺剂的成本效益
Jefferson Antonio Buendía1, Diana Guerrero Patino2
1Departamento de Farmacología y Toxicología, Facultad de Medicina, Grupo de Investigación en Farmacología y Toxicología, Universidad de Antioquia, Carrera 51D #62-29, Medellín, Colombia. jefferson.buendia@gmail.com.
Cost effectiveness and resource allocation : C/E
|December 24, 2025
概括
对于哥伦比亚间歇性过敏鼻炎的成年人来说, cetirizine 和 fexofenadine 是最具成本效益的口服抗胰岛素药物. 这些选项提供了高的净货币收益,使它们成为管理AR的有价值选择.
科学领域:
- 药物经济学 药物经济学
- 过敏和免疫学 过敏和免疫学
- 卫生经济学 卫生经济学
背景情况:
- 过敏性鼻炎 (AR) 是一种普遍存在的全球疾病,带来了大量的医疗费用和降低了生活质量.
- 建议使用鼻腔内皮质类固醇,但口服抗胰岛素在低收入和中等收入国家很常见.
- 这项研究的重点是哥伦比亚间歇性AR新一代口服H1抗胰岛素的成本效益.
研究的目的:
- 在哥伦比亚,对患有间歇性过敏性鼻炎的成年人进行新一代口服H1抗胰岛素的成本效益分析.
- 根据临床有效性和不良事件,比较各种口服抗胰岛素的成本效益.
- 为了确定哥伦比亚环境中间歇性AR最经济可行的治疗选择.
主要方法:
- 用一个28天的决策树模型来比较多种抗胰岛素的成本和质量调整寿命年 (QALY).
- 关于临床有效性和不良事件的数据来源于系统性审查和网络元分析.
- 净货币收益 (NMB) 用哥伦比亚的支付意愿值计算,并进行敏感性分析以解决不确定性.
主要成果:
- 确定了10毫克的利津和180毫克的费克索芬阿丁是唯一具有优越NMB的非主导策略.
- 确定性分析表明, cetirizine 的总成本较低,每 QALY 的 ICER 为 349.62 美元.
- 概率分析支持fexofenadine在各种值中具有成本效益,而 cetirizine在较低的值中仍然具有竞争力.
结论:
- 塞蒂里辛10毫克和fexofenadine 180毫克是哥伦比亚中断性过敏性鼻炎的成年人最具成本效益的口服H1抗组胺药物.
- 这两种药物都显示出高净货币效益,并且在敏感性分析中没有占据主导地位.
- 这些发现为管理哥伦比亚间歇性AR提供了有价值的经济指导.
相关概念视频
Upper Respiratory Drugs: First and Second-Generation Antihistamines
990
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
990
Drugs Used in Upper Respiratory Disorders: Overview
594
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
594
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Upper Respiratory Drugs: Decongestants
767
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
767
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Adrenergic Agonists: Mixed-Action Agents
1.3K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.3K


